Colin Farrell has made the hard decision to put his 21-year-old son James, who suffers from Angelman syndrome, in a long-term care facility. “It’s tricky – some parents will say, ‘I want to take care ...

For the first time, the Brazilian Football Confederation (CBF) joins Angelman Brasil in a national awareness campaign about Angelman Syndrome, a rare and still little-known genetic condition. The ...

Though rare, Angelman syndrome brings many insights into what can be deeply complex about genetic disorder conditions and ...

ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 ...

Dr. Joseph D'Orazio shares his experience working as a doctor and raising a child who has a rare disease, Angelman syndrome. D'Orazio explains how the experience has impacted his professional and ...

Ionis Pharmaceuticals, which is developing a treatment for the rare neurological disease of Angelman syndrome (AS), turned to Lifetime Television’s “Behind the Mystery” series to increase public ...

Ciavarro lacks the 15th chromosome and doesn’t sleep well, experiences seizures, and suffers from a neurological condition ...

Colin Farrell is elaborating on a big parenting decision he made. The “Penguin” star, 48, revealed in a new interview with Candis magazine that he and his ex, model Kim Bordenave, put their ...